Published • loading... • Updated
Lek Launches 400 Million-Euro Plant in Lendava
Summary by Delo
3 Articles
3 Articles
Biopharmaceuticals: High-tech center brings more than 300 jobs and strengthens Sandoz's European network in Pomurje.
·Ljubljana, Slovenia
Read Full Article
This is the largest investment in the integration of the production of similar biologics that the company has made in Slovenia so far, and the second major biopharmaceutical investment completed this year.
·Slovenia
Read Full Article
The Opening of Biopharmaceuticals: What Advantages Does It Bring to Pomurje and Slovenia in General?
The pharmaceutical company Lek opened a new high-tech center for the production of active ingredients for similar biologics Biopharmaceuticals in Lendava today. At 400 million euros, it is the largest investment in Lek's history and one of the largest foreign investments in Slovenia, said Gregor Makuc, CEO of Lek and President of Sandoz Slovenia.
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
